CG102

Bacterial meningitis and meningococcal septicaemia (CG102)

  • Clinical guidelines CG102
  • Issued: June 2010
    • The management of bacterial meningitis and meningococcal septicaemia in children and young people younger than 16 years in primary and secondary care

      This guideline offers best practice advice on the care of children and young people younger than 16 years with bacterial meningitis and meningococcal septicaemia.

      • Bacterial meningitis is an infection of the surface of the brain (meninges) by bacteria that have usually travelled there from mucosal surfaces via the bloodstream. Meningococcal septicaemia – or blood poisoning – occurs when the bacteria in the blood multiply uncontrollably.
      • Meningococcal disease can appear as meningococcal meningitis or meningococcal septicaemia, or a combination of both.

      • July 2010 Please note that there is an amended version of the Quick Reference Guide (QRG) for the NICE clinical guideline 102, Bacterial meningitis and meningococcal septicaemia guideline, which was published in June 2010 now available on line. The amended QRG now reflects the action required when meningococcal meningitis is confirmed in children older than 3 months (page 14). The slide set has also been revised.

        September 2010:

        Corrections to the full version of Bacterial meningitis and meningococcal septicaemia (clinical guideline 102) published in June 2010

        A correction has been made to the full version of this guideline, as well as to the NICE version and the Quick Reference Guide.

        The hydrocortisone dosage in the recommendation relating to steroid replacement therapy using low-dose corticosteroids in children and young people with shock that is unresponsive to vasoactive agents has been corrected (NICE guideline recommendation 1.4.45). The original recommendation stated:

        In children and young people with shock that is unresponsive to vasoactive agents, steroid replacement therapy using low-dose corticosteroids (hydrocortisone 0.25 mg/m2 four times daily) should be used only when directed by a paediatric intensivist.

        The corrected recommendation reads:

        In children and young people with shock that is unresponsive to vasoactive agents, steroid replacement therapy using low-dose corticosteroids (hydrocortisone 25 mg/m2 four times daily) should be used only when directed by a paediatric intensivist.

      • Other information

        NICE Pathways

        This guidance has been incorporated into the following NICE Pathways, along with other related guidance and products.

        Visit the NICE Pathway: bacterial meningitis and meningococcal septicaemia

        How this guidance was produced

        Background information

      This page was last updated: 30 July 2013

    • Guideline formats

      Query

      Guideline review

      Review decision date: June 2013

      • No guideline review documents found

Patient

The summary of the key recommendations in the guidance written for patients, carers and those with little medical knowledge and may be used in local patient information leaflets.

Quick Reference Guide

The quick reference guide presents recommendations for health professionals

NICE Guideline

The published NICE clinical guideline, contains the recommendations for health professionals and NHS bodies.

Full Guideline

The published full clinical guideline for specialists with background, evidence, recommendations and methods used.

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.